Tivantinib: a new promising mesenchymal–epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma

Author: Rimassa Lorenza   Personeni Nicola   Simonelli Matteo   Santoro Armando  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.9, Iss.2, 2013-02, pp. : 153-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content